Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC); Notice of Charter Renewal
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through November 25, 2024.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 243 (Tuesday, December 20, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 243 (Tuesday, December 20, 2022)]
[Notices]
[Page 77843]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-27481]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention (CDC)/Health Resources
and Services Administration (HRSA) Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment (CHAC); Notice of Charter
Renewal
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of charter renewal.
-----------------------------------------------------------------------
SUMMARY: This gives notice under the Federal Advisory Committee Act of
October 6, 1972, that the Centers for Disease Control and Prevention
(CDC)/Health Resources and Services Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
(CHAC), Centers for Disease Control and Prevention, Department of
Health and Human Services, has been renewed for a 2-year period through
November 25, 2024.
FOR FURTHER INFORMATION CONTACT: CAPT Deron Burton, MD, JD, MPH, Acting
Designed Federal Officer, Centers for Disease Control and Prevention
(CDC)/Health Resources and Services Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
(CHAC), CDC, HHS, 1600 Clifton Road, NE, Mailstop US8-6, Atlanta,
Georgia 30329-4027; Telephone (404) 639-1506; Email: <a href="/cdn-cgi/l/email-protection#c58187b0b7b1aaab85a6a1a6eba2aab3"><span class="__cf_email__" data-cfemail="95d1d7e0e7e1fafbd5f6f1f6bbf2fae3">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-27481 Filed 12-19-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.